Here is Why Ultragenyx Pharmaceutical (RARE) is One of the Best Buy-the-Dip Stocks

As of June 5 closing, the statement sentiment astir Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) remained powerfully bullish. Based connected a median one-year people terms of $51.87, the banal offers much than 122% upside.

Sergey Nivens/Shutterstock.com

Back connected May 21, Kristen Kluska from Cantor Fitzgerald accrued the people terms for the banal from $84 to $96, resulting successful a revised upside imaginable of astir 312%. The expert reiterated her Overweight standing connected the stock, based connected a greater statistical occurrence probability of GTX-102 to cure Angelman syndrome. This stems from the Phase 3 design, enabling the threshold for statistical value to beryllium compartmentalized into 2 endpoints, i.e., MDRI and Bayley-4 cognitive earthy score.

More recently, the U.S. Food and Drug Administration issued draught guidance designed to streamline the improvement and regulatory submission process for promising quality cistron therapies. After it is finalized, the model volition picture however developers tin usage existent technological data, nationalist information, and established level expertise. These see manufacturing, chemistry, and power data, arsenic good arsenic nonclinical and objective outcomes.

Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), being a cardinal subordinate successful this space, is expected to payment from this development. This regulatory effectiveness focuses connected cistron therapy products that usage genome editing successful quality somatic cells.

Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) develops caller therapies, with a absorption connected identifying, acquiring, and commercializing products for uncommon and ultra-rare familial diseases. It has a beardown accent connected cistron therapy and covers assorted stages of objective trials. The institution is presently going done precocious currency pain with the purpose of turning profitable from 2027 onwards.

While we admit the imaginable of RARE arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 33 Stocks That Should Double successful 3 Years and 15 Stocks That Will Make You Rich successful 10 Years.

Disclosure: None. Follow Insider Monkey connected Google News.